Takahiro Miyake

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 8 EPO patents. Top assignees: Novartis Ag, Carna Biosciences, Inc., Irm LLC. Active years: 2009-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiro Miyake. Retrieved from https://idiyas.com/inventor/takahiro-miyake-ip02oroq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 57.1

CIPO Patents = 3

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 99(Granted Patents)

Location History:

Tsukuba, JP (2009 - 2011)
Ibaraki, JP (2011)
Hyogo, JP (2012)
Kobe, JP (2014 - 2017)

Company Filing History:

Carna Biosciences, Inc.

4. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2009-2017

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9656995 - Triazine derivative (2017-05-23),

2. 8759365 - Organic compounds (2014-06-24),

3. 8263590 - Pyrimidine derivatives (2012-09-11),

4. 7964592 - 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders (2011-06-21),

5. 7910585 - Pyrimidine derivatives (2011-03-22),

6. 7893074 - 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders (2011-02-22),

7. 7531546 - Spiro-substituted pyrrolo[2,3-D]pyrimidines as cathepsin inhibitors (2009-05-12),

Title: Takahiro Miyake: Innovator in Organic Chemistry

Introduction

Takahiro Miyake is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of organic chemistry, particularly through his innovative patents. With a total of 7 patents to his name, Miyake has established himself as a key figure in the development of novel compounds.

Latest Patents

Miyake's latest patents include a triazine derivative aimed at providing a novel compound of the formula (I). This invention focuses on creating a compound that acts as an inhibitor of CETP, which can be utilized for treating disorders or diseases mediated by CETP or responsive to its inhibition. Another significant patent involves organic compounds, which also presents a compound of formula (I) with similar applications in medical treatment.

Career Highlights

Throughout his career, Takahiro Miyake has worked with notable companies such as Novartis AG and Irm LLC. His work in these organizations has allowed him to further his research and development in organic chemistry, leading to impactful innovations.

Collaborations

Miyake has collaborated with esteemed colleagues, including Eiji Kawahara and Keiichi Masuya. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Takahiro Miyake is a distinguished inventor whose work in organic chemistry has led to significant advancements in the field. His innovative patents and collaborations highlight his commitment to improving medical treatments through scientific research.

Profile summary based on public USPTO records.